We strive to extend survival in some of the most aggressive forms of cancer. Patient images reflect patient(s) health status when photographed.
Baar, Switzerland
- Tweets 2,175
- Following 229
- Followers 2,773
- Likes 1,090
Novocure announced today that management will participate in two upcoming investor events. Read more in our press release: investor.novocure.com/news-r…
2
694
Novocure today reported financial results for the second quarter that ended June 30, 2026. Read more in our press release: investor.novocure.com/news-r…
228
Novocure will report financial results for the second quarter 2026 on July 23, 2026, before the U.S. financial markets open. Read more in our press release: investor.novocure.com/news-r…
1
268
Novocure announced today that its treatment has received CE Mark for the treatment of adult patients with locally advanced pancreatic cancer of exocrine origin, concomitant with gemcitabine and nab-paclitaxel in accordance with guideline recommendations. investor.novocure.com/news-r…
3
274
Novocure announced topline results today from the Phase 3 TRIDENT trial. Read more in our press release: investor.novocure.com/news-r…
1
1
309
Novocure today reported financial results for the first quarter that ended March 31, 2026. Read more in our press release: investor.novocure.com/news-r…
294
Novocure will report financial results for the first quarter 2026 on April 30, 2026. Read more in our press release: novocure.com/novocure-report…
301
Novocure announced positive results today from the Phase 2 PANOVA-4 trial of Tumor Treating Fields (TTFields) therapy. Read more in our press release: novocure.com/novocure-announ…
1
1
379
Today Novocure announced that Japan’s Ministry of Health, Labour and Welfare approved reimbursement for its treatment for non-small cell lung cancer through the country’s National Health Insurance coverage.
Read more in our press release: novocure.com/novocure-announ…
5
355
Novocure today reported financial results for the quarter and full year ended December 31, 2025.
Read more in our press release: novocure.com/novocure-report…
313
We are thrilled to see the news of our Optune Pax approval featured on the Nasdaq tower this morning.
Read more about the approval in our latest press release: novocure.com/us-fda-approves…
Thank you to the team at Nasdaq!
4
2
12
861
Yesterday, the U.S. Food and Drug Administration (FDA) approved Novocure’s treatment for adult patients with locally advanced pancreatic cancer concurrently with gemcitabine and nab-paclitaxel.
Read more in our press release: novocure.com/us-fda-approves…
4
14
726
The U.S. Food and Drug Administration (FDA) has approved Novocure’s treatment for adult patients with locally advanced pancreatic cancer concurrently with gemcitabine and nab-paclitaxel.
novocure.com/us-fda-approves…
5
14
1,961
Novocure today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2025. Read more in our press release. novocure.com/novocure-announ…
1
438
Novocure announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Read more in our press release: novocure.com/novocure-presen…
4
572
Novocure today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Read more in our press release: novocure.com/novocure-appoin…
1
1
533
Novocure announced today that management will participate in the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025. Read more in our press release: novocure.com/novocure-partic…
303
Novocure today reported financial results for the third quarter that ended September 30, 2025. Read more in our press release: novocure.com/novocure-report…
1
270
Novocure to present data at the 2025 European Association of Neuro-Oncology (EANO) Meeting, held October 16-19 in Prague, Czech Republic, and the European Society for Medical Oncology (ESMO) Congress 2025, held October 17-21 in Berlin, Germany. novocure.com/novocure-presen…
359
Novocure will report financial results for the third quarter 2025 on October 30, 2025, before the U.S. financial markets open. Read more in our press release: novocure.com/novocure-report…
1
268